Role of farnesoid X receptor in determining hepatic ABC transporter expression and liver injury in bile duct-ligated mice
View abstract on PubMed
Summary
This summary is machine-generated.Farnesoid X receptor (FXR) is crucial for maintaining bile salt export pump (Bsep) expression during cholestasis. FXR deficiency alters adaptive transporter responses and liver injury patterns, suggesting FXR modulators could treat liver diseases.
Area Of Science
- Hepatology
- Molecular Biology
- Pharmacology
Background
- Cholestasis, a liver condition, alters the expression of hepatic adenosine triphosphate-binding cassette (ABC) transporters.
- The nuclear bile acid receptor, farnesoid X receptor (FXR), is a key regulator of bile acid homeostasis and transporter expression.
Purpose Of The Study
- To investigate the role of FXR in mediating changes in hepatic ABC transporter expression during cholestasis.
- To determine FXR's role in the development of liver injury associated with cholestasis.
Main Methods
- Studied hepatic ABC transporter expression (Mrp 2-4, Bsep) in common bile duct-ligated (CBDL) FXR knockout and wild-type mice.
- Assessed liver injury markers (serum enzymes, bilirubin, bile acids) and liver histology.
- Performed cholangiomanometry and bile duct morphometry.
Main Results
- CBDL increased Mrp 3 and Mrp 4 expression independently of FXR; Bsep expression was maintained in wild-type but lost in FXR knockout mice.
- FXR knockout mice showed reduced biliary pressure and ductular proliferation but developed disseminated liver cell necroses.
- Mortality and liver enzyme levels did not differ between groups.
Conclusions
- FXR is essential for maintaining Bsep expression, a critical factor in the cholestatic phenotype.
- FXR-independent upregulation of Mrp 3 and Mrp 4 contributes to adaptive transporter responses in cholestasis.
- FXR modulation may offer therapeutic potential for cholestatic liver diseases.